Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 19:22
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
Writers strike felt in missing NBC stars, absence of Fox schedule for TV sales pitches
Ex-chemical safety agency chief misused $90K on trips, renovations and other expenses, watchdog says
Cathay Pacific to pay deferred dividend to HK govt as operations return to normal
US import prices rise less than expected in September
Burger King must face lawsuit claiming its Whoppers are too small
ADDING MULTIMEDIA Thomas Park Management - Chosen as Exclusive Property Management Company for USNA Alumni Association and Foundation’s New Home in Annapolis
ECB to pause in September, say slim majority of economists: Reuters poll
Shoot United™ Launches Rimfire Educational Video Series